Eisai publishes additional detailed analyses from lecanemab phase 2b study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. META
2. SPY
3. USO
4. MU
5. IONS
6. MSFT
7. COST
8. LEVI
9. CG
10. AVAV

Go back to Eisai publishes additional detailed analyses from lecanemab phase 2b study
BARNES GROUP, Inc. (NYSE: B) Delayed: 36.83 --0 (-0%)
Previous Close $36.83    52 Week High $44.27 
Open $36.83    52 Week Low $30.07 
Day High $36.83    P/E 28.11 
Day Low $36.83    EPS $1.31 
Volume 4,927       

BIOAMBER, Inc. (NASDAQ: BIOA) Delayed: 24.89 --0 (-0%)
Previous Close $24.89    52 Week High $8.73 
Open $24.89    52 Week Low $2.86 
Day High $24.89    P/E N/A 
Day Low $24.89    EPS $-3.82 
Volume 68